Crumly & Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $616K | Buy |
7,063
+218
| +3% | +$19K | 0.15% | 84 |
|
|
2025
Q1 | $615K | Buy |
6,845
+312
| +5% | +$28K | 0.17% | 83 |
|
|
2024
Q4 | $522K | Buy |
6,533
+397
| +6% | +$31.7K | 0.14% | 90 |
|
|
2024
Q3 | $552K | Sell |
6,136
-115
| -2% | -$10.4K | 0.15% | 95 |
|
|
2024
Q2 | $492K | Buy |
6,251
+442
| +8% | +$34.8K | 0.14% | 97 |
|
|
2024
Q1 | $506K | Hold |
5,809
| – | – | 0.13% | 102 |
|
|
2023
Q4 | $479K | Buy |
5,809
+2,785
| +92% | +$229K | 0.14% | 97 |
|
|
2023
Q3 | $237K | Buy |
3,024
+164
| +6% | +$12.9K | 0.09% | 104 |
|
|
2023
Q2 | $252K | Buy |
+2,860
| New | +$252K | 0.1% | 106 |
|
|
2022
Q4 | – | Sell |
-4,910
| Closed | -$396K | – | 112 |
|
|
2022
Q3 | $396K | Buy |
4,910
+211
| +4% | +$17K | 0.16% | 78 |
|
|
2022
Q2 | $422K | Buy |
4,699
+393
| +9% | +$35.3K | 0.18% | 71 |
|
|
2022
Q1 | $478K | Buy |
4,306
+563
| +15% | +$62.5K | 0.18% | 72 |
|
|
2021
Q4 | $382K | Sell |
3,743
-550
| -13% | -$56.1K | 0.15% | 79 |
|
|
2021
Q3 | $538K | Buy |
4,293
+109
| +3% | +$13.7K | 0.25% | 68 |
|
|
2021
Q2 | $519K | Buy |
4,184
+998
| +31% | +$124K | 0.25% | 66 |
|
|
2021
Q1 | $376K | Buy |
3,186
+220
| +7% | +$26K | 0.22% | 60 |
|
|
2020
Q4 | $346K | Sell |
2,966
-102
| -3% | -$11.9K | 0.24% | 47 |
|
|
2020
Q3 | $319K | Buy |
3,068
+631
| +26% | +$65.6K | 0.27% | 37 |
|
|
2020
Q2 | $223K | Sell |
2,437
-108
| -4% | -$9.88K | 0.21% | 46 |
|
|
2020
Q1 | $230K | Buy |
+2,545
| New | +$230K | 0.28% | 39 |
|